Chimpanzee adenovirus- and MVA-vectored respiratory syncytial virus vaccine is safe and immunogenic in adults.

Respiratory syncytial virus (RSV) causes respiratory infection in annual epidemics, with infants and the elderly at particular risk of developing severe disease and death. However, despite its importance, no vaccine exists. The chimpanzee adenovirus, PanAd3-RSV, and modified vaccinia virus Ankara, M...

Full description

Bibliographic Details
Main Authors:	Green, C, Scarselli, E, Sande, C, Thompson, A, de Lara, C, Taylor, K, Haworth, K, Del Sorbo, M, Angus, B, Siani, L, Di Marco, S, Traboni, C, Folgori, A, Colloca, S, Capone, S, Vitelli, A, Cortese, R, Klenerman, P, Nicosia, A, Pollard, A
Format:	Journal article
Language:	English
Published:	American Association for the Advancement of Science 2015

Chimpanzee adenovirus- and MVA-vectored respiratory syncytial virus vaccine is safe and immunogenic in adults.

Similar Items